The table that follows provides a summary reference guide to pharmacological treatment. It was prepared from data available in September 2010. Prescribers should refer to the British National Formulary for Children (BNFc) and summary of product characteristics for each drug for full and up-to-date details of licensing. Informed consent should be obtained and documented for the use of any drug outside the licensed indications.
Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.
The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.
The rights of National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.
Royal College of Physicians (UK), London
National Clinical Guideline Centre (UK). Sedation in Children and Young People: Sedation for Diagnostic and Therapeutic Procedures in Children and Young People [Internet]. London: Royal College of Physicians (UK); 2010 Dec. (NICE Clinical Guidelines, No. 112.) Appendix J, Licensing indications.